Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lyell Immunopharma Inc.

    NASDAQ: LYEL · Real-Time Price · USD
    10.62
    -0.14 (-1.30%)
    At close: Aug 15, 2025, 3:59 PM
    10.58
    -0.38%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Lyell Immunopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -342.99M -234.63M -183.12M -250.22M
    Depreciation & Amortization
    		 19.63M 20.25M 18.02M 13.62M
    Stock-Based Compensation
    		 33.14M 47.08M 81.92M 62.2M
    Other Working Capital
    		 114K 1.96M -82.68M 3.92M
    Other Non-Cash Items
    		 130.94M 183K -6.68M 4.62M
    Deferred Income Tax
    		 n/a n/a 2.32M 39.51M
    Change in Working Capital
    		 -3.12M 3.42M -82.02M 4.01M
    Operating Cash Flow
    		 -162.39M -163.69M -169.56M -126.25M
    Capital Expenditures
    		 -464K -2.69M -24.28M -65.5M
    Cash Acquisitions
    		 -31.35M -186.73M -12.74M 673.47M
    Purchase of Investments
    		 -394.71M -476.88M -406.32M -673.47M
    Sales Maturities Of Investments
    		 548.94M 663.61M 419.05M 617.4M
    Other Investing Acitivies
    		 n/a 186.73M 12.74M -673.47M
    Investing Cash Flow
    		 122.42M 184.05M -11.54M -121.57M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a -457K -461K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -76K 1.74M 10.63M 9.44M
    Financial Cash Flow
    		 1.33M 1.74M 10.63M 401.24M
    Net Cash Flow
    		 -38.64M 22.1M -170.46M 153.42M
    Free Cash Flow
    		 -162.86M -166.38M -193.83M -191.75M

    Add to Watchlist